Retrospective chart review of severe infusion reactions with rituximab, cetuximab, and bevacizumab in community oncology practices: assessment of clinical consequences

By Schwartzberg Lee  

Supportive Care in Cancer, Vol. 16, Iss. 4, 2008-04 ,pp. : 393-398

Springer Publishing Company

Access to resources Recommend Favorite

Successful management of infusion reaction accompanying the start of cetuximab therapy

By Melichar Bohuslav   Cerman Jaroslav   Malířová Eva  

Supportive Care in Cancer, Vol. 15, Iss. 4, 2007-04 ,pp. : 445-449

Springer Publishing Company

Access to resources Recommend Favorite

Re-treatment with cetuximab in patients with severe hypersensitivity reactions to cetuximab. Two case reports.

By Nielsen Dorte L.   Pfeiffer Per   Vittrup Jensen Benny  

Acta Oncologica, Vol. 45, Iss. 8, 2006-12 ,pp. : 1137-1138

Informa Healthcare

Access to resources Recommend Favorite

Transient severe hyperbilirubinemia after hepatic arterial infusion of oxaliplatin in patients with liver metastases

By Garcia Sean   Atkins Johnique   Falchook Gerald   Tsimberidou Apostolia   Hong David   Trivedi Meghana   Kurzrock Razelle  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 6, 2013-12 ,pp. : 1265-1271

Springer Publishing Company

Access to resources Recommend Favorite

Severe Anaphylactic Reactions to Oxaliplatin

By Tournigand C.   Maindrault-Goebel F.   Louvet C.   de Gramont A.   Krulik M.  

European Journal of Cancer, Vol. 34, Iss. 8, 1998-07 ,pp. : 1297-1298

Elsevier

Access to resources Recommend Favorite